{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:06Z","timestamp":1790649786392,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T00:00:00Z","timestamp":1418428800000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.cca.2013.11.028","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T01:45:35Z","timestamp":1386207935000},"page":"76-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels"],"prefix":"10.1016","volume":"429","author":[{"given":"Lillian Harboe","family":"Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Vin\u00edcius Ferreira","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Carolina Figueiredo","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci Maria S.","family":"Dusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana A.","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Braga","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria das Gra\u00e7as","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.11.028_bb0005","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/ehp097","article-title":"COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment","volume":"30","author":"Pulcinelli","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2013.11.028_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/diacare.29.s1.06.s43","article-title":"Diagnosis and classification of diabetes mellitus","volume":"29","author":"American Diabetes Association","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2013.11.028_bb0015","series-title":"American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","first-page":"199S","article-title":"Antiplatelet drugs","volume":"133","author":"Patrono","year":"2008"},{"key":"10.1016\/j.cca.2013.11.028_bb0020","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.108.768283","article-title":"Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid. Determinants and effect on cardiovascular risk","volume":"118","author":"Eikelboom","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.11.028_bb0025","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1016\/j.thromres.2009.11.016","article-title":"Post interventional cardiology urinary thromboxane correlates with PlateletMapping\u00ae detected aspirin resistance","volume":"125","author":"Carrol","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.cca.2013.11.028_bb0030","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0049-3848(87)90103-4","article-title":"Paired analysis of urinary thromboxane B2 metabolites in humans","volume":"47","author":"Catella","year":"1987","journal-title":"Thromb Res"},{"key":"10.1016\/j.cca.2013.11.028_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/dmrr.794","article-title":"Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects","volume":"24","author":"Formoso","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.cca.2013.11.028_bb0040","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2013.11.028_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1538-7836.2010.04122.x","article-title":"Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan","volume":"9","author":"Alexandru","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cca.2013.11.028_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/CH-2010-1327","article-title":"Mean platelet volume in patients with prehypertension and hypertension","volume":"45","author":"Varol","year":"2010","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.cca.2013.11.028_bb0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1213\/01.ane.0000196526.28277.45","article-title":"Increased fibrinolysis and platelet activation in elderly patients undergoing coronary bypass surgery","volume":"102","author":"Pleym","year":"2006","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.cca.2013.11.028_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ntr\/ntq235","article-title":"Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study","volume":"13","author":"Frost-Pineda","year":"2011","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"10.1016\/j.cca.2013.11.028_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2011.00930.x","article-title":"Platelet activation in obesity and metabolic syndrome","volume":"13","author":"Santilli","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.cca.2013.11.028_bb0075","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2013.11.028_bb0080","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/ATVBAHA.108.183160","article-title":"Antiplatelet actions of statins and fibrates are mediate by PPARs","volume":"29","author":"Ali","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.11.028_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1479164110383994","article-title":"Platelet abnormalities in diabetes mellitus","volume":"7","author":"Ferreiro","year":"2010","journal-title":"Diab Vasc Dis Res"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:01:07Z","timestamp":1762113667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113004750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":16,"alternative-id":["S0009898113004750"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.11.028","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}